Back to BARCLAYS PLC BARCLAYS PLC

AKROAKRO
26 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in AKERO THERAPEUTICS INC

As of its Q3 2025 13F, Barclays held 487,230 shares of AKRO (Akero Therapeutics), worth $23.1M. Barclays' 13F filings listed AKRO from Q3 2019 to Q3 2025, 25 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$61,000

Total Shares Change

-2,657

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$47.62
0
2025-Q3
Decreased
487,230
-8.7%
$23.1M0.0%$47.62
0
2025-Q2
Increased
533,416
+333.1%
$28.5M0.0%$56.19
46
2025-Q1
Decreased
123,163
-7.3%
$5M0.0%$42.72
0
2024-Q4
Increased
132,837
+4.0%
$3.7M0.0%$27.96
28
2024-Q3
Increased
127,668
+127.9%
$3.7M0.0%$28.24
43
2024-Q2
Decreased
56,016
-20.8%
$1.3M0.0%$23.46
0
2024-Q1
Decreased
70,681
-71.3%
$1.8M0.0%$25.26
0
2023-Q4
Increased
246,274
+87.4%
$5.8M0.0%$23.35
42
2023-Q3
Decreased
131,446
-8.1%
$6.6M0.0%$50.58
0
2023-Q2
Increased
143,078
+85.3%
$6.7M0.0%$44.64
42
2023-Q1
Decreased
77,224
-25.4%
$3M0.0%$37.80
0
2022-Q4
Increased
103,552
+8616.5%
$5.7M0.0%$54.80
44
2022-Q3
Decreased
1,188
-90.2%
$40,0000.0%$29.80
0
2022-Q2
Increased
12,078
+58.7%
$114,0000.0%$9.57
31
2022-Q1
Decreased
7,610
-78.5%
$107,0000.0%$14.60
0
2021-Q4
Increased
35,430
+151.8%
$749,0000.0%$21.42
40
2021-Q3
Increased
14,068
+156.9%
$315,0000.0%$22.35
38
2021-Q2
Decreased
5,476
-57.1%
$136,0000.0%$25.61
0
2021-Q1
Increased
12,757
+114.8%
$369,0000.0%$28.40
38
2020-Q4
Decreased
5,938
-27.3%
$153,0000.0%$26.11
0
2020-Q3
Decreased
8,169
-53.0%
$252,0000.0%$31.37
0
2020-Q2
Increased
17,399
+525.4%
$434,0000.0%$22.89
39
2020-Q1
Decreased
2,782
-44.6%
$59,0000.0%$17.18
0
2019-Q4
Increased
5,018
+88.9%
$112,0000.0%$27.27
34
2019-Q3
New
2,657
-
$61,0000.0%$19.83
32

Other major holders of AKRO: Janus Henderson Group Ltd., BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used